MARATTO

article · Alexandria Journal of Science and Technology

Plasma and 3D Printing in Drug Discovery and Development

Abstract

The necessity of sustainable technology to accelerate the drug discovery &development pipeline is urgent. Plasma, the fourth state of matter, can be utilized in green organic synthesis for preparation of active pharmaceutical ingredients (APIs) or for obtaining their starting materials. Based on the type of reactor, the resulting organic material will be generated. Carbon dioxide, the most common polluted gas, is used as a building block in organic synthesis. Plasma can capture CO2 to generate methanol. The future work is to synthesize aspirin for its starting material through plasma. Another green chemistry technique is 3D printing. 3D printing is an additive process, where multiple layers from CAD (computer-aided design) drawings are laid down one after another to create different shapes. 3D printing is used to build reproducible catalysis to perform certain reactions as multicomponent or Mannich reactions. nifidipine, fluoxetine, atropine, or ethacrynic acid could be prepared by such technology.

Research topics

  • Nanomaterials for catalytic reactions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/ajst.2025.452266

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.